QPID Health Announces Formation of Advisory Board

Group of nationally recognized healthcare IT and policy leaders to provide strategic guidance 

Boston – April 23, 2014 – QPID Health, an innovative provider of clinical intelligence software solutions, today announced the formation of the Company’s first industry Advisory Board, which will provide insights on the concerns of healthcare leaders and guidance on corporate and product strategy. In the last year, the company has rolled out new products and expanded its customer and employee bases.

“Today, EHRs have proven to be great repositories for data, but physicians and other clinicians still struggle to gain what’s clinically relevant from the data they hold,” said Mike Doyle, QPID Health chief executive officer. “QPID Health solves that problem by unlocking value from the data within existing EHRs. In our evolving outcomes-based health economy, QPID’s technology is helping drive more efficient and improved care. We are thrilled to have attracted this group of industry thought leaders who share our passion for helping clinicians deliver the best possible care to patients.”

With the global EHR market expected to reach $22.3 billion by the end of 2015, the board will help QPID solidify its place in the market in order to serve the massive demand from hospitals and health systems looking to leverage EHRs in new and measureable ways. Passionate practicing physicians created the Company’s platform as part of a Massachusetts General Hospital informatics initiative in 2005 and QPID Health officially launched in 2012. True to its roots, development teams are led by doctors to address the practical concerns of users in the clinical environment.

Through its scalable cloud-based architecture, QPID leverages advanced concept-based natural language processing (NLP) to extract insights from data stored in EHR systems and other clinical repositories. In 2013, its first year of commercial operation, the company supported a growing user base ending the year with 4000 active quarterly users, and 2.96 million clinical encounters impacting 340,000 patients.

QPID Health advisory board members:

David W. Bates, MD, MSc is Chief of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, and Professor of Health Policy and Management at the Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness.

John D. Halamka, MD, MS is a Professor of Medicine at Harvard Medical School and Chief Information Officer of Beth Israel Deaconess Medical Center, responsible for all clinical, financial, administrative and academic information technology serving 3000 doctors, 14000 employees and two million patients. He is also Chairman of the New England Healthcare Exchange Network (NEHEN), co-Chair of the national HIT Standards Committee, co-Chair of the Massachusetts HIT Advisory Committee and a practicing Emergency Physician.

Julia Adler-Milstein, PhD is an Assistant Professor at University of Michigan whose research focuses on policy and management issues related to the use of IT in healthcare delivery. She is an expert in health information exchange, and studies the productivity and efficiency of electronic health records as well as organizational strategies to maximize EHR effectiveness.

John E. Osborn, JD, MIPP is a senior advisor with the international law firm Hogan Lovells, executive in residence with the healthcare group of Warburg Pincus, a regular contributor to Forbes.com and a faculty member at the University of Washington, Seattle. John was general counsel with Fortune 1000 companies Cephalon and US Oncology, and served in the U.S. Department of State and as a member of the U.S. Advisory Commission on Public Diplomacy.

Robert M. Wachter, MD is a Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF’s Department of Medicine, and Chief of UCSF’s 60-faculty Division of Hospital Medicine. Dr. Wachter coined the term “hospitalist” and is generally considered the academic leader of the hospitalist movement. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine.

About QPID Health

QPID Health’s clinical intelligence software automatically delivers the most relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The solution was developed at Massachusetts General Hospital to address the data overload problem engendered by the spread of electronic health records. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. The company is venture backed by Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization (MGPO), and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contacts:

Nigel Smith
NextStep Communications
(781) 308-3317

Amy Krane
617 292 7743, x 122

1 reply

Trackbacks & Pingbacks

  1. […] CEO of Abide Therapeutics. We welcome Alan as the newest member of the QPID Health Advisory Board, announced in April. He is a pioneer in the field of innate immunity and previously served as senior vice president and […]

Comments are closed.